XML 61 R32.htm IDEA: XBRL DOCUMENT v3.22.4
Note 10 - Share Capital (Tables)
12 Months Ended
Nov. 30, 2022
Statement Line Items [Line Items]  
Disclosure of reserves within equity [text block]
   

Restricted Shares
($)

   

Share Options
($)

   

Warrants
($)

   

Total
($)

 

Balance at November 30, 2020

    26       5,536       3,541       9,103  

Options exercised

    -       (752 )     -       (752 )

Restricted share rights vested

    (105 )     -       -       (105 )

Share-based compensation

    116       1,745       -       1,861  

Balance at November 30, 2021

    37       6,529       3,541       10,107  

Options exercised

    -       (429 )     -       (429 )

Restricted share rights vested

    (140 )     -       -       (140 )

Share-based compensation

    138       2,254       -       2,392  

Balance at November 30, 2022

    35       8,354       3,541       11,930  
Disclosure of number and weighted average exercise prices of share options [text block]
  

Number of

Options

  

Weighted

Average

Exercise Price

($)

 

Balance at November 30, 2020

  10,732,000   1.51 

Granted

  3,015,000   1.84 

Exercised(1)

  (1,197,850)  1.00 

Expired

  (105,000)  2.50 

Balance at November 30, 2021

  12,444,150   1.63 

Granted

  4,694,445   1.61 

Exercised(2)

  (705,520)  1.58 

Cancelled/Forfeited

  (175,000)  2.01 

Expired

  (2,255,000)  1.70 

Balance at November 30, 2022

  14,003,075   1.61 
Disclosure of indirect measurement of fair value of goods or services received, share options granted during period [text block]
  

November 30,

2022

  

November 30,

2021

 

Risk-free interest rate

  3.54%  1.03%

Expected life (years)

  2.87   2.74 

Expected volatility

  61.25%  59.80%

Expected dividend yield

  0.00%  0.00%

Estimated forfeiture rate

  2.87%  3.82%
Disclosure of range of exercise prices of outstanding share options [text block]
  

Options Outstanding

  

Options Exercisable

 

Exercise

Prices

 

Number of

Options

Outstanding

  

Weighted

Average

Exercise

Price

($)

  

Weighted

Average

Remaining

Contractual

Life

(years)

  

Number of

Options

Exercisable

  

Weighted

Average

Exercise

Price

($)

  

Weighted

Average

Remaining

Contractual

Life

(years)

 

$0.78 - $0.96

  1,837,500   0.79   1.00   1,837,500   0.79   1.00 

$0.97 - $1.57

  3,099,500   1.13   1.74   2,889,500   1.11   1.54 

$1.58 - $1.60

  4,145,500   1.60   4.98   1,036,375   1.60   4.98 

$1.61 - $1.83

  2,516,250   1.83   3.95   1,885,000   1.83   3.95 

$1.84 - $3.38

  2,404,325   2.67   2.93   2,306,695   2.70   2.88 
   14,003,075   1.61   3.20   9,955,070   1.61   2.57 
Disclosure of earnings per share [text block]
  

Year ended November 30, 2022

  

Year ended November 30, 2021

 
  

Loss for

  

Weighted

  

Loss

  

Income for

  

Weighted

  

Income

 
  

the year

  

average shares

  

per share

  

the year

  

average shares

  

per share

 
  ($)  

outstanding

  ($)  ($)  

outstanding

  ($) 

Basic income (loss) per share

  (13,200)  154,045,370   (0.09)  100,355   149,407,112   0.67 

Effect of dilutive securities:

                        

Stock options

  -   -   -   -   3,102,078   - 

Diluted income (loss) per share

  (13,200)  154,045,370   (0.09)  100,355   152,509,190   0.66 
Restricted share rights [member]  
Statement Line Items [Line Items]  
Disclosure of number and weighted average exercise prices of other equity instruments [text block]
  

Number of

RSRs

  

Weighted Average
Value

($)

 

Balance at November 30, 2020

  49,040   2.88 

Granted

  50,000   1.83 

Vested

  (36,540)  2.88 

Balance at November 30, 2021

  62,500   2.04 

Granted

  239,490   1.60 

Vested

  (72,564)  1.94 

Balance at November 30, 2022

  229,426   1.61